Latest Industry Trends News
Global PMI Rises to 52.5 in January 2026
The J.P. Morgan Global PMI Composite Output Index increased to 52.5 from 52.0 in December, signaling faster economic expansion driven by manufacturing and services. Manufacturing output grew at the joint-highest pace since June 2024 due to rising new orders, though business confidence stayed subdued amid geopolitical concerns.
Price pressures intensified, raising doubts on expansion sustainability.
Tech Giants Ramp Up AI Spending to $660 Billion
Alphabet, Amazon, Meta, and Microsoft plan $660 billion in spending this year, 60% more than 2025, sparking investor fears over returns. Amazon raised its 2026 capex to $200 billion, causing shares to tumble 5.6% post-earnings.
This echoes concerns from Microsoft's prior numbers, weighing on tech stocks.
US Manufacturing Confidence Jumps Unexpectedly
US manufacturing business confidence rose sharply in January after three years in recession territory, supporting growth expectations with tax cuts ahead. Both US and Canadian manufacturing sectors expanded for the first time in a year.
However, weak labor data and trade policy uncertainty tempered optimism.
Sector Rotation Hits Tech, Boosts Energy
Technology faces sharp selloff due to AI capex concerns, while energy outperforms amid risk-off sentiment. Defensive sectors like consumer staples and utilities gain as investors rotate.
Emerging markets dipped 0.6%, though India rose 4% on US tariff cuts to 18%.
Aduro Clean Technologies Shows 73% Revenue Growth
Aduro Clean Technologies projects 73% annual revenue growth, far exceeding Canada's 6.2% market rate. The firm develops water-based chemical recycling tech, with market cap at CA$532.61 million.
It eyes profitability within three years at 58.91% earnings growth.
Gan & Lee Pharmaceuticals Expands Globally
Gan & Lee appointed Dr. John Wang as Chief Strategy Officer and partnered with Lupin for India distribution. EMA recommended its insulin glargine, boosting EU presence amid 59.4% past-year earnings growth.
Projected 20.2% revenue growth signals strong biotech trajectory.